{"id":"W4242919730","doi":"10.21203/rs.2.107/v2","title":"Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double blind, parallel group placebo-controlled clinical trial Protocol","year":2019,"lang":"en","type":"preprint","venue":"Research Square","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Arthritis Society","funders":"European League Against Rheumatism; King's Health Partners; King's College London; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Abatacept; Double blind; Medicine; Rheumatoid arthritis; Protocol (science); Placebo; Clinical trial; Physical therapy; Arthritis; Single blind; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01155498,0.006543644,0.009814543,0.001879574,0.00248849,0.002859093,0.002862182,0.007108369,0.04979914],"category_scores_gemma":[0.008748158,0.003010306,0.003704353,0.001863474,0.003329634,0.002506826,0.001378965,0.005884895,0.01327002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001914607,"about_ca_system_score_gemma":0.006970367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001396105,"about_ca_topic_score_gemma":0.002424417,"domain_scores_codex":[0.9929114,0.003415077,0.0007194793,0.00106818,0.000815203,0.00107067],"domain_scores_gemma":[0.996766,0.0007395726,0.0006709177,0.000447475,0.0005266307,0.000849445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9767492,0.005493558,0.0002581822,0.002865133,0.0003590136,0.0000692078,0.00008750914,0.0003510093,0.001219663,0.0007003425,0.003600354,0.008246902],"study_design_scores_gemma":[0.9801687,0.01313089,0.0008241442,0.0002021056,0.0002586659,0.00002842213,0.0000183845,0.0003589301,0.0002249076,0.0003722731,0.00438025,0.00003238093],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.03097007,0.001701284,0.004099586,0.0005466214,0.0009976459,0.9518313,0.00482238,0.0004344101,0.004596701],"genre_scores_gemma":[0.04826513,0.001301605,0.007342265,0.001131171,0.0007212593,0.9332736,0.001884572,0.00006140891,0.006019096],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04979914,"threshold_uncertainty_score":0.1665947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1920843139077548,"score_gpt":0.5261227980130302,"score_spread":0.3340384841052754,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}